Tesla and Moderna Stock Started 2022 Very Differently. What History Says Happens Next.

 Tesla and Moderna Stock Started 2022 Very Differently. What History Says Happens Next.

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.

https://www.barrons.com/articles/tesla-tsla-moderna-mrna-stocks-2022-historical-performance-51641315965


  • Order Reprints

  • Print Article

The first trading day of 2022 saw both the Dow Jones Industrial Average and S&P 500 finish at record highs for only the sixth time in history and the second time in 30 years.

The stock market action on Monday also saw the usual divergence of winners and losers: Tesla (ticker: TSLA) was the biggest riser among S&P 500 constituents, climbing 13.5%, while Moderna (MRNA) was the biggest loser, posting a 7.5% drop.

What…


Related post